tiprankstipranks
Trending News
More News >
RxSight backs FY25 revenue view $160M-$175M, consensus $170.34M
PremiumThe FlyRxSight backs FY25 revenue view $160M-$175M, consensus $170.34M
3d ago
RxSight’s Earnings Call: Growth Amid Challenges
Premium
Company Announcements
RxSight’s Earnings Call: Growth Amid Challenges
4d ago
Nike initiated, GM downgraded: Wall Street’s top analyst calls
Premium
The Fly
Nike initiated, GM downgraded: Wall Street’s top analyst calls
26d ago
RxSight’s Market Challenges and Revised Growth Projections Lead to Hold Rating
PremiumRatingsRxSight’s Market Challenges and Revised Growth Projections Lead to Hold Rating
1M ago
RxSight’s Strategic Growth and Resilience Justify Buy Recommendation
Premium
Ratings
RxSight’s Strategic Growth and Resilience Justify Buy Recommendation
1M ago
RxSight price target lowered to $17 from $22 at Wells Fargo
Premium
The Fly
RxSight price target lowered to $17 from $22 at Wells Fargo
1M ago
RxSight downgraded to Underperform from Buy at BofA
PremiumThe FlyRxSight downgraded to Underperform from Buy at BofA
1M ago
RxSight’s Growth Potential Amid Challenges: A Buy Recommendation by David Saxon
Premium
Ratings
RxSight’s Growth Potential Amid Challenges: A Buy Recommendation by David Saxon
1M ago
RxSight’s Undervaluation and Growth Potential Justify Buy Rating Despite Revenue Shortfall
Premium
Ratings
RxSight’s Undervaluation and Growth Potential Justify Buy Rating Despite Revenue Shortfall
1M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100